進升集團控股(01581.HK)供股已成為無條件 所得款項淨額約5200萬港元
格隆匯9月22日丨進升集團控股(01581.HK)發佈公吿,於2022年9月7日下午四時正,已接獲可認購合共1.485億股供股股份(相當於供股項下提呈發售的供股股份總數約71.6%)的有效申請合共為四份。餘下5896.6萬股未獲認購供股股份(相當於供股項下提呈發售的供股股份總數約28.4%)將受補償安排規限。
2022年9月16日,配售事項下所有5896.6萬股未獲認購供股股份已成功按每股股份0.26港元的價格配售。因此,並無根據補償安排可分派予不行動股東的淨收益。
因此,供股所得款項總額約為5400萬港元,而扣除開支後的供股所得款項淨額約為5200萬港元。
由於供股章程所載有關供股的全部條件已達成,供股已於2022年9月19日下午四時正成為無條件。
預期繳足股款的供股股份將自2022年9月26日上午九時正開始於聯交所買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.